| ADH | Alcohol dehydrogenase |
| ALD | Alcohol-associated liver disease |
| ALDH | Aldehyde dehydrogenase |
| ASK1 | Apoptosis signal-regulating kinase 1 |
| BA(s) | Bile acid(s) |
| BBB | Blood–brain barrier |
| CNS | Central nervous system |
| CYP2E1 | Cytochrome P450 2E1 |
| DAMPs | Damage-associated molecular patterns |
| FGF21 | Fibroblast growth factor 21 |
| FMT | Fecal microbiota transplantation |
| FXR | Farnesoid X receptor |
| G-CSF | Granulocyte colony-stimulating factor |
| GLP-1 | Glucagon-like peptide-1 |
| HCC | Hepatocellular carcinoma |
| HE | Hepatic encephalopathy |
| HSC(s) | Hepatic stellate cell(s) |
| IL | Interleukin |
| JNK | c-Jun N-terminal kinase |
| LPS | Lipopolysaccharide |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MetALD | Metabolic dysfunction-associated steatotic liver disease and increased alcohol intake |
| MEOS | Microsomal ethanol-oxidizing system |
| NAD+ | Nicotinamide adenine dinucleotide |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK | Natural killer |
| NMDA | N-methyl-D-aspartate (receptor) |
| PAMPs | Pathogen-associated molecular patterns |
| PARP | Poly(ADP-ribose) polymerase |
| ROS | Reactive oxygen species |
| RNS | Reactive nitrogen species |
| SCFA(s) | Short-chain fatty acid(s) |
| TGF-β | Transforming growth factor-beta |
| Th17 | T helper 17 |
| TLR4 | Toll-like receptor 4 |
| TNF-α | Tumor necrosis factor-alpha |
| Treg | Regulatory T cell |